Herpes simplex virus type 1 (HSV-1) is an alphaherpesvirus that establishes latency primarily in the cells of the human peripheral nervous system. During latency, the viral genome becomes a circular episome (41, 44) and is at least partially bound by nucleosomes (13). The normal cascade of lytic gene expression is silenced (49) except for the expression of a set of latency-associated transcripts (LATs) from two identical loci in the inverted-repeat sequences surrounding the unique long (U L ) component of the genome (12, 45, 52, 57) . Two separate regions that possess promoter activity have been identified: latency-active promoter 1 (LAP1) (2, 14, 16, 36, 67) and the TATA-less latency-active promoter 2 (LAP2) (8, 22, 65) . LAP1 is the predominant promoter during latency, while LAP2 is the predominant promoter driving LAT expression during lytic infection (13, 14) . The two regions may be functionally interdependent, since LAP1 in the absence of LAP2 cannot express most foreign genes during latency in an ectopic locus (37) or when the foreign gene is introduced into the LAT locus immediately downstream of the LAP1 TATA box near the 8.3-kb minor LAT transcription start site (40). In contrast, introduction of a lacZ reporter gene into the LAT intron downstream of the LAP1-LAP2 complex results in long-term reporter gene expression during latency (7, 23). Long-term expression is also seen when the LAP2 promoter is used to drive the expression of lacZ in an ectopic locus such as the glycoprotein C gene (22).
Herpes simplex virus type 1 (HSV-1) is an alphaherpesvirus that establishes latency primarily in the cells of the human peripheral nervous system. During latency, the viral genome becomes a circular episome (41, 44) and is at least partially bound by nucleosomes (13) . The normal cascade of lytic gene expression is silenced (49) except for the expression of a set of latency-associated transcripts (LATs) from two identical loci in the inverted-repeat sequences surrounding the unique long (U L ) component of the genome (12, 45, 52, 57) . Two separate regions that possess promoter activity have been identified: latency-active promoter 1 (LAP1) (2, 14, 16, 36, 67) and the TATA-less latency-active promoter 2 (LAP2) (8, 22, 65) . LAP1 is the predominant promoter during latency, while LAP2 is the predominant promoter driving LAT expression during lytic infection (13, 14) . The two regions may be functionally interdependent, since LAP1 in the absence of LAP2 cannot express most foreign genes during latency in an ectopic locus (37) or when the foreign gene is introduced into the LAT locus immediately downstream of the LAP1 TATA box near the 8.3-kb minor LAT transcription start site (40) . In contrast, introduction of a lacZ reporter gene into the LAT intron downstream of the LAP1-LAP2 complex results in long-term reporter gene expression during latency (7, 23) . Long-term expression is also seen when the LAP2 promoter is used to drive the expression of lacZ in an ectopic locus such as the glycoprotein C gene (22) .
While LAP2 lacks a recognizable TATA box, it does contain sequences found in other promoters. LAP2 from HSV-1 strain 17 contains a stretch of 23 consecutive T residues (T 23 ) and a CT-rich element, the latter of which is found in a variety of TATA-less promoters as well as promoters involved in signal transduction (3, 27, 30, 32, 54, 56) . Initial characterization of LAP2 revealed sequences between Ϫ388 and Ϫ11 to be required in transient expression of a reporter gene following transfection of cells in culture. Both the uninterrupted 23-nucleotide thymidine (T 23 ) sequence (Ϫ175 to Ϫ151), and a CT-rich region (Ϫ92 to Ϫ57) were found to be required for full LAP2 activity in mammalian cells (21) . Plasmid constructs containing the T 23 sequence and the CT-rich region were sensitive to S1 nuclease digestion, suggesting that these sequences were capable of forming non-B-DNA structures in vitro and may function to alter chromatin structure, allowing this region of the HSV genome to escape the transcriptional silencing that occurs during latency.
In vitro binding studies revealed that the CT-rich region binds two proteins: Sp1 (5, 29) and NSEP-1 (33) . Cotransfection of LAP2 with an Sp1 expression vector in Drosophila Schneider SL-2 cells enhanced expression from LAP2 (21) . Additionally, the CT-rich region of LAP2 was able to induce expression in cis when placed upstream of a minimal promoter. However, deletion of the CT element did not abrogate the ability of Sp1 to induce transcription from LAP2, suggesting that Sp1 can bind elsewhere in LAP2, making the CT element functionally redundant for Sp1 binding. The reduction of LAP2 activity in the CT deletion mutant in mammalian cells suggested that other factors in addition to Sp1 may be interacting with elements within LAP2.
In this report, we identify four sequence elements in LAP2 that are protected from nuclease digestion by either HeLa nuclear extracts and/or purified Sp1. Transient-expression assays with substitution mutants revealed several important cisacting elements within these protected regions. Electrophoretic mobility shift analysis (EMSA) with the prominent positive-acting cis element, the poly(T) stretch, identified one of the binding proteins as being related or identical to the high-mobility-group proteins, HMG I(Y) (46, 51, 53, 55) . We show that recombinant HMG I(Y) facilitates Sp1 binding to
RESULTS

Four regions of LAP2 are protected in footprinting assays.
Four regions of LAP2 exhibited protection from DNase I with either nuclear extract (HeLa) or purified Sp1 on both the coding (Fig. 1A) and noncoding (Fig. 1B) strands. We have designated these FP1 (Ϫ290 to Ϫ250), FP2 (Ϫ200 to Ϫ175), FP3 (Ϫ110 to Ϫ96), and FP4 (Ϫ88 to Ϫ45), numbered in order from 5Ј to 3Ј on the coding strand of the promoter. Footprinting with nuclear extracts from the neuroblastoma cell line B103 revealed similar protection to that observed with the HeLa extracts (Fig. 1B) ; therefore, no cell-type-specific protections were observed. Purified Sp1 protein protected FP1, FP3, and FP4, whereas nuclear extracts protected FP1, FP2, and FP3, indicating that FP2 was unique to the nuclear extracts and FP4 was unique to Sp1. Additionally, the patterns of protection within FP1 were different between Sp1 and the nuclear extracts. Sp1 bound at a sequence further downstream within LAP2, while the extracts bound further upstream (Fig. 1B) . Sp1 titration in the footprinting assay demonstrated that Sp1 binds to the sequences protected in FP4 at lower concentrations than it binds to the sequences protected by FP3 (data not shown), suggesting that Sp1 has a higher affinity for sequences in FP4. The DNase I protection results and a comparison of HSV-1 LAP2 sequences from HSV-1 KOS and HSV-1 17 are presented in Fig. 2 .
Substitution mutations in the footprinted regions of LAP2 have significant effects on reporter gene activity in Vero cells. To test the relative importance of each of the protected regions to promoter activity, 11 individual 14-bp substitution mutants were generated and tested in transient-transfection assays for reporter gene expression (Fig. 3) in Vero cells. Vero cells (an African green monkey kidney cell line) were used for transfections since they are commonly used to study HSV-1 lytic infections. However, abundant protease activity in Vero cell extracts limited their utility for footprinting and gel shift experiments. Transfection of LAP2 promoter constructs showed that mutants 1A and 1C displayed reduced promoter activity. Mutant 1A corresponds to the region within FP1 pro- tected by nuclear extract, while 1C corresponds to the region protected by Sp1 in FP1.
Since DNase I did not cleave naked LAP2 DNA in the poly(T) stretch (Fig. 1) , making it impossible to detect protein binding in this region, mutations within the T stretch were generated to further evaluate the role of this element in promoter function. Mutants 2B, which corresponded to the majority of FP2 upstream of the T stretch, reduced expression fivefold. Mutant 2C, which disrupted part of FP2 as well part of T 23 , reduced expression almost ninefold. The 14-base alteration of T 23 (mutant 2D) reduced expression to negligible levels and thus has the most pronounced deleterious effect on promoter function. FP2 was still detected upon footprint analysis of mutant 2D, suggesting that a separate factor binds upstream of T 23 (data not shown).
In contrast to the other mutants, mutation of FP3 (mutant 3) caused a surprising 10-fold increase in expression from LAP2. Mutant 4A almost doubled reporter gene activity, whereas mutant 4C reduced LAP2 activity nearly fivefold.
Transient-expression assays were also performed in HeLa cells to eliminate the possibility that different transcription factors in Vero cells were interacting with LAP2 compared with those available in HeLa cells. Expression from wild-type LAP2CAT, as well as mutants 2D and 3, was similar to expression from these constructs in Vero cells, indicating that cis elements in LAP2 behave similarly in both cell types (data not shown).
The T 23 region is bound by a HeLa cell protein.
Since mutant 2D exhibited the most severe reduction in gene expression, we performed EMSA on probes of either wild-type (T) or mutant 2D (TM) (eliminating 14 bases of the T stretch) poly(T) region. EMSA performed in the presence one of three nonspecific competitors, poly(dA-dT) ⅐ poly(dA-dT), poly(dGdC) ⅐ poly(dG-dC), or poly(dI-dC) ⅐ poly(dI-dC), revealed strong binding only in the presence of poly(dG-dC) ⅐ poly(dGdC) (data not shown). The mobility shift observed when this probe was bound by HeLa extract was small relative to that observed with Sp1, suggesting that a binding protein with a molecular size smaller than that of Sp1 was complexing with this region of LAP2. EMSA with the poly(T) region revealed three or more complexes (Fig. 4) . Complex 1 showed a weaker interaction than did complexes 2 and 3, which ran as an intense VOL. 16, 1996 HSV LATENCY-ACTIVE PROMOTER 2 TRANSCRIPTION 5395 doublet and bound the majority of the probe. Comparison of binding affinity to the wild type and 2D mutant probe detected a greater affinity for the wild-type sequence. Probe T was completely bound by protein, resulting in no free probe, in contrast to the situation observed with probe TM. Competition of each probe with nonlabeled probes revealed that T could compete with itself and TM more effectively, confirming its stronger affinity for the binding factors. Since complex 1 is seen only with probe T but is competed for by both T and TM, and since probe T contains an additional 14 bases of thymidine, complex 1 may be composed of a multimer of the proteins responsible for complex 2 and 3 binding. The binding of all the probe T primarily by complexes 2 and 3 and the inability to demonstrate complete self competition indicates that these proteins are present in great abundance. T 23 -binding protein has properties of the HMG I(Y) protein. The low apparent molecular weight and T oligomer affinity of complexes 2 and 3 ( Fig. 4) suggested that the proteins present in these complexes may be related to HMG I(Y) proteins (19, 55) . HMG molecules bind DNA in the minor groove (51) and are heat stable (58, 60) . To test the heat stability of the T 23 -binding activity, EMSA was performed with heattreated extracts. The T 23 binding activity was heat stable (Fig.  5A) . In contrast, heat treatment of the extract eliminated Sp1 binding (Fig. 5B) . Minor-groove-binding drugs block DNA binding by HMG proteins (60) , and thus we tested the effect of two minor-groove-binding drugs on the T 23 binding activity (Fig. 5) . Both diminazene aceturate and distamycin inhibited T 23 binding activity effectively (Fig. 5A) , although distamycin had a greater inhibitory effect at these concentrations. In contrast, distamycin had no effect on binding by Sp1 (Fig. 5B) , a major-groove-binding protein. The heat stability and minorgroove properties of complexes 2 and 3 further suggest that they contain factors related to HMG proteins. To determine whether the T 23 -binding activity was immunologically related to HMG I(Y), we tested an anti-HMG I(Y) antiserum (55) for its ability to block the formation of any of the complexes seen with the T 23 oligomer. Addition of anti-HMG I(Y) antiserum either before or after incubation with heat-treated nuclear extracts prevented the formation of complex 3 (Fig. 6) , in contrast to the addition of preimmune serum, which had no effect on complex formation. (Fig. 7, lane 1) . As increasing concentrations of GST-HMG I(Y) were added, the formation of the Sp1-containing complexes (complexes 1 and 2) was greatly increased. Stimulation of Sp1 binding requires the HMG I(Y) moiety, since added GST had no effect on Sp1 binding (Fig. 7, lane 11) . Thus, the binding of HMG I(Y) to the FIG. 5. T 23 -binding activity has properties of HMG proteins. Minor-groovebinding drug EMSA competition low-molecular-weight nuclear proteins for the T stretch probe (A) the control consensus Sp1 probe (B) are shown. EMSA was performed with the LAP2 T stretch probe by preincubating the probe with either 0, 1 mM, 1 M, or 1 nM diminazene aceturate (Berenil) or distamycin followed by binding with either heat-treated or non-heat-treated nuclear extracts and subsequent electrophoresis. All drug competitions were done with heat-treated extract. F, free probe; O, non-heat-treated extract; H, heat-treated extract. (Fig. 8) . Transfection efficiency was normalized to the expression of ␤-galactosidase from a separate reporter plasmid. Inhibition by the HMG I(Y) antisense plasmid was specific to the LAP2 promoter, since no inhibition of LAP1-CAT reporter plasmid was observed. This experiment provides direct evidence that the expression of the HMG I(Y) proteins is required for LAP2 promoter function in vivo.
DISCUSSION
Using DNase I footprinting, we have identified four regions in LAP2, designated FP1 through FP4, that bind to nuclear factors. Substitution mutations in these four regions were constructed and tested in transfection experiments. In all cases, mutations in the footprinted regions were found to confer changes in the transcriptional activity of LAP2, thus validating this approach to identify cis-acting elements. Mutations is FP1 (mutants 1A and 1C), FP2 (mutants 2B and 2C), and FP4 (mutant 4C) caused between two-and eightfold reductions in transcription of the LAP2-CAT reporter gene, indicating that these sequences function as activation elements. Two mutations, 3 and 4A, caused a significant increase (10-and 2-fold, respectively) in transcription, indicating that these sequences act as repression elements. Footprinting experiments with nuclear extracts from a neuroblastoma cell line yielded similar regions of protection. Thus, we were unable to identify sequences that might account for the transcription regulation observed in neuronal cells.
The identities of two of the trans-acting factors that bind to and regulate the LAP2 promoter have been determined. First, the GC-rich nature of this region led us to test the ability of the Sp1 transcription factor to bind to LAP2. Purified Sp1 bound to sequences in FP1, FP3, and FP4. The pattern of DNase I protection by purified Sp1 in FP1 was not identical to that observed with nuclear extract, suggesting that other protein factors were also bound to these regions. Evidence that Sp1 activates LAP2 transcription comes from experiments with Drosophila Schneider SL2 cells, in which transfection of a Sp1 expression plasmid caused an increase in LAP2 transcription (21) . FP4 is uniquely protected by Sp1 (Fig. 2) . Mutation 4C resulted in a fivefold decrease in transcription. This mutation had the strongest effect on transcription of any of the regions that bind to Sp1, perhaps as a result of its proximity to the start site of LAP2. Sp1 sites that are close to the transcription start site have previously been shown to have a stronger effect on transcription than do more distal Sp1 sites (48, 63) . Sp1 is important for full induction of promoter activity in many cases (35, 42, 61, 62) and may also be involved in maintaining expression from constitutive promoters (4, 24, 38) . Sp1 may maintain promoter function by constitutively binding to its site, thereby preventing methylation of the promoter (4, 24, 38) and elimination of methylation repression (6, 9, 25) . Previous work has suggested that the HSV-1 genome is partially methylated during latency (17) and that the LAP2 region possesses many CpG islands (11) , although the role of methylation in the function of the LAPs during latency remains to be elucidated.
Sp1 also bound to FP3 in vitro; however, mutation of this region resulted in a significant increase in LAP2 transcription. The increased expression observed with this mutant suggests that region 3 functions as a cis-acting repressor element. Factors other than Sp1 may be responsible for the footprint seen with nuclear extract. These factors may function by blocking Sp1 binding at region 3 and/or region 4, as has been described with Sp1 (1, 10, 20, 64) and other transcription factors (31) . Alternatively, region 3 may function by directly recruiting a repressor protein (28) .
The second trans-acting factor to be identified as a regulator of LAP2 was HMG I(Y). The LAP2 promoter in the KOS strain contains a stretch of 23 consecutive thymidine residues (T 23 ). This region of LAP2 even as naked DNA is not cut by DNase I, and therefore it was not possible to determine by DNase I protection assays if this region was bound by proteins in the HeLa nuclear extract. However, mutation of the T 23 element resulted in a greater than 20-fold reduction in promoter activity (Fig. 3) . To determine if this region was bound by a nuclear factor, EMSA was performed with a T 23 -containing DNA oligonucleotide. An abundant nuclear factor that showed a greater affinity for the wild-type T 23 sequence over the 2D mutant sequence was detected (Fig. 4) , demonstrating a correlation between transcriptional activity and the ability of this cis element to bind specific proteins. We have shown that the DNA-binding properties of factors which bind to the T stretch include heat stability, binding competition with poly(dA-dT) ⅐ poly(dA-dT), and inhibition by the minorgroove-binding drugs distamycin and berenil (Fig. 5) . These properties are shared by a number of proteins in the HMG class. Finally, one of the T 23 -binding factors (complex 3) is blocked by a polyclonal antiserum specific for HMG I(Y) (Fig.  6 ). Taken together, these properties strongly suggest that one the factors that binds to the T stretch is related or identical to HMG I(Y).
The HMG I and HMG Y proteins are closely related splice variants that have been shown to interact with several promoters (19, 61, 62) . Site-directed mutagenesis studies have re- (61, 62) . HMG I(Y) has no intrinsic transcriptional activation activity (55), rather, it has been shown to transactivate promoters through mechanisms which facilitate the activity of other transcription factors. For example, HMG I(Y) is associated with nuclear scaffolding regions (51) and can mobilize the transcriptional repressor histone H1 from scaffold-associated regions in vitro (66) , resulting in derepression of transcription from those elements. Also, binding of HMG I(Y) alters the structure of the bound DNA (18) . This structural perturbation may result in bending of the DNA, bringing distant transcription factors already bound to the promoter into closer proximity, thus facilitating interaction between these factors and bringing more transactivating elements closer to the start of transcription. This increase in the proximity of transcription factors may result in stronger recruitment of the basal transcriptional machinery, resulting in higher levels of transcription. Mutation of the T 23 element resulted in a more severe decrease in transcription than did mutation of any of the other footprinted regions, suggesting that this mutation may well disrupt synergistic interactions that occur between multiple elements in the LAP2 promoter. The regulation of both LAP1 and LAP2 is of considerable interest because of their unique ability to escape the transcriptional silencing that occurs during latency. We show here that recombinant HMG I protein facilitates the binding of Sp1 to the LAP2 promoter. Whether this increase in Sp1 binding is related to changes in DNA structure has not been demon- The effect of mutation 2D on expression is much more pronounced than its effect on HMG I(Y) binding. This mutation eliminates 14 bases of the T stretch yet leaves 9 thymidines remaining at the 3Ј end. The minimal AT stretch length required for HMG I(Y) binding is 6 bases (51), explaining why HMG I(Y) can still bind the mutant oligomer. However, the ability of HMG I(Y) to recruit transcription factors also depends on the phase of the HMG I(Y) site relative to the binding site of the other factors, including those bound to the regions that make up FP1 and FP4. Also, it is worth noting that the T 23 stretch present in HSV-1 KOS is not present in other HSV-1 strains. In HSV-1 17, the T 23 stretch is a smaller T 9 stretch. Our results led to the prediction that the T 9 stretch in HSV-1 17 would also bind HMG I(Y) and that mutation of the T 9 stretch would block both binding by HMG I(Y) and transcriptional regulation by HMG I(Y). Validation of this prediction awaits further experimentation.
The results presented in this study further delineate the sequences of LAP2 that are required for promoter function.
Viruses with a precise deletion of LAP2 express the 2-kb LAT RNA during latent infections at a lower level than do wild-type viruses (8) . This result suggests that LAP2 either acts as a functional promoter during latency or contributes to the activity of LAP1. Deletion of the 370-bp StyI fragment, which removes much of the upstream LAP2 region (Ϫ588 to Ϫ218), has little or no effect on LAT expression during latent or lytic growth (39) . However, this mutation leaves intact most of the LAP2 proximal promoter and in particular the LAP2 start site, the CT element, and the T 9 tract present in HSV-1 17, which our studies suggest are the critical LAP2 promoter elements. Studies of HSV-2 LAT expression suggest that the LAP2 region is important for enhancing the expression of LAP1 but that LAP2 itself may not be an independent promoter element (65) . The DNA sequence of HSV-1 and HSV-2 in the LAP2 region is poorly conserved; however, it is worth noting that the LAP2 sequence in HSV-2, like HSV-1, lacks a recognizable TATA element and includes the CT-rich element but that unlike HSV-1, HSV-2 LAP2 lacks a poly(T) tract (34) . It seems possible that an HMG protein with different sequence specificity will contribute to HSV-2 LAP2 activity. Our studies indicate that HSV-1 LAP2 has the ability to act as an independent promoter element in transfection assays and that it can drive the expression of the 2-kb LAT independently of LAP1 during lytic growth. Unraveling the exact role of HSV-1 LAP2 during latency, whether it acts as an independent promoter or as an enhancer of LAP1, will be facilitated by an increased understanding of the cis-acting elements that contribute to LAP2 function.
